ReviewFrontiers in oncology2019

Temozolomide Induced Hypermutation in Glioma: Evolutionary Mechanisms and Therapeutic Opportunities.

Paul Daniel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.